Intuitive Surgical, Inc. $ISRG Shares Acquired by Silvant Capital Management LLC

Silvant Capital Management LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 88,875 shares of the medical equipment provider’s stock after purchasing an additional 2,046 shares during the period. Intuitive Surgical accounts for 1.4% of Silvant Capital Management LLC’s portfolio, making the stock its 16th largest position. Silvant Capital Management LLC’s holdings in Intuitive Surgical were worth $39,748,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Tobam boosted its holdings in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the period. Kilter Group LLC bought a new position in Intuitive Surgical in the 2nd quarter worth about $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $27,000. Caitlin John LLC bought a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $30,000. Finally, Guerra Advisors Inc acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $37,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $485.85 on Wednesday. The firm has a market cap of $172.54 billion, a price-to-earnings ratio of 61.58, a price-to-earnings-growth ratio of 3.81 and a beta of 1.66. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $603.88. The firm’s 50 day moving average price is $518.26 and its two-hundred day moving average price is $512.74.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s revenue was up 18.8% compared to the same quarter last year. During the same period last year, the company posted $2.21 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several analyst reports. Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. Royal Bank Of Canada increased their price target on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a research note on Wednesday. Truist Financial upped their price objective on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $615.86.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the transaction, the senior vice president owned 907 shares of the company’s stock, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Gary S. Guthart sold 24,500 shares of the business’s stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the sale, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 37,802 shares of company stock worth $19,945,322 in the last quarter. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.